Dieulafoy lesion (hemorrhagic) of stomach and duodenum
ICD-10 K31.82 is a billable code used to indicate a diagnosis of dieulafoy lesion (hemorrhagic) of stomach and duodenum.
A Dieulafoy lesion is a rare but significant cause of gastrointestinal bleeding, primarily occurring in the stomach and duodenum. It is characterized by a large, tortuous artery that is located close to the mucosal surface, which can lead to hemorrhage when the overlying mucosa is eroded. Clinically, patients may present with hematemesis (vomiting blood) or melena (black, tarry stools), indicating upper gastrointestinal bleeding. The anatomy involved includes the gastric and duodenal regions where these lesions typically occur, often near the lesser curvature of the stomach. Disease progression can be acute, with sudden onset of bleeding, or chronic, with intermittent episodes. Diagnostic considerations include endoscopy, which is the gold standard for identifying Dieulafoy lesions, and imaging studies may be used to assess the extent of bleeding. Prompt diagnosis and intervention are crucial to prevent significant morbidity and mortality associated with massive gastrointestinal hemorrhage.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K31.82 specifically covers Dieulafoy lesions of the stomach and duodenum, which are characterized by arterial bleeding due to a mucosal defect. It is important to differentiate this condition from other causes of upper gastrointestinal bleeding.
K31.82 should be used when there is a confirmed diagnosis of a Dieulafoy lesion, particularly when endoscopic findings support this diagnosis. It is distinct from other codes for gastrointestinal hemorrhage that do not specify the lesion type.
Documentation should include endoscopic findings, clinical symptoms, treatment details, and any imaging studies performed. Clear notes on the nature of the bleeding and the intervention undertaken are crucial for supporting the use of K31.82.
